Gary P. Fischetti
CIK: 0001929510
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANIK
Anika Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 4, 2026ANIK
Anika Therapeutics, Inc.
Purchase(P)Direct1K shares at avg. $20.32$20K - Aug 3, 2026ANIK
Anika Therapeutics, Inc.
Purchase(P)Direct1K shares at avg. $20.75$21K - Jun 18, 2026ANIK
Anika Therapeutics, Inc.
Award(A)Direct10.4K shares- - Jun 20, 2025ANIK
Anika Therapeutics, Inc.
Award(A)Direct14.2K shares-
1-4 of 4 transactions
About Fischetti Gary P
Fischetti Gary P (SEC CIK 0001929510) files insider reports with the SEC as Director of Anika Therapeutics, Inc. (ANIK).
Signal8 holds 3 ownership filings by Fischetti Gary P, all Form 4s, filed between Jun 24, 2025 and Aug 5, 2026. Those filings report 4 transactions, from Jun 20, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fischetti Gary P's filings is in BEDFORD, MA.
Recent filings by Fischetti Gary P
Other insiders filing for Anika Therapeutics, Inc. (ANIK)
- HENNEMAN JOHN B III, Director
- Richard Stephen, Director
- Capper Joseph H, Director
- CONLEY SHERYL L, Director
- Griffin Stephen D., President and CEO
- McLeod Ian, SVP, CAO & Treasurer